ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31
Annovis Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.96−0.03 (-3.36%)
Close on Oct 19, 2026
- Market cap
- $36.02M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Annovis Bio has not reported a dividend
No dividend per share appears in Annovis Bio's annual filings since fiscal 2018.